Citius Oncology, Inc.

NasdaqCM:CTOR Stock Report

Market Cap: US$44.4m

Citius Oncology Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Leonard Mazur

Chief executive officer

US$2.2m

Total compensation

CEO salary percentage7.6%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Leonard Mazur's remuneration changed compared to Citius Oncology's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-US$23m

Sep 30 2024US$2mUS$166k

-US$21m

Jun 30 2024n/an/a

-US$20m

Mar 31 2024n/an/a

-US$17m

Dec 31 2023n/an/a

-US$16m

Sep 30 2023US$662kUS$153k

-US$13m

Compensation vs Market: Leonard's total compensation ($USD2.20M) is above average for companies of similar size in the US market ($USD639.27K).

Compensation vs Earnings: Leonard's compensation has increased whilst the company is unprofitable.

CEO

Leonard Mazur (79 yo)

less than a year

Tenure

US$2,201,250

Compensation

Mr. Leonard L. Mazur is Chairman, Chief Executive Officer & President of Citius Oncology, Inc. from August 12, 2024. He has been Chief Executive Officer of Citius Pharmaceuticals, Inc. since May 01, 2022....

Leadership Team

NamePositionTenureCompensationOwnership
Leonard Mazur
Chairmanless than a yearUS$2.20mno data
Myron Holubiak
Executive Vice Chairman & Secretaryless than a yearUS$1.28m0%
$ 0
Myron Czuczman
Chief Medical Officerless than a yearUS$995.00k0%
$ 0
Jaime Bartushak
CFO & Treasurerless than a yearno data0%
$ 0

0.6yrs

Average Tenure

70.5yo

Average Age

Experienced Management: CTOR's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Leonard Mazur
Chairmanless than a yearUS$2.20mno data
Myron Holubiak
Executive Vice Chairman & Secretaryless than a yearUS$1.28m0%
$ 0
Dennis McGrath
Independent Directorless than a yearno data0%
$ 0
Suren Dutia
Independent Directorless than a yearno data0%
$ 0
Joel Mayersohn
Independent Director2.4yrsno datano data
Robert Smith
Independent Directorless than a yearno datano data
Carol Webb
Independent Directorless than a yearno data0%
$ 0
Eugene Holuka
Independent Directorless than a yearno data0%
$ 0

0.6yrs

Average Tenure

72yo

Average Age

Experienced Board: CTOR's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 17:37
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Citius Oncology, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael OkunewitchMaxim Group